Whitehead Scientific’s Post

Check out the latest report from IMIR Market Research Pvt. Ltd. on the 𝗕𝗿𝗲𝗮𝘀𝘁 𝗖𝗮𝗻𝗰𝗲𝗿 𝗟𝗶𝗾𝘂𝗶𝗱 𝗕𝗶𝗼𝗽𝘀𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 Outlook and Geography Forecast till 2028 Don't miss out on this opportunity to stay informed about the latest trends in the industry. Breast Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report By Product Services (Reagent Kits, Instruments, Services), By Circulating Biomarker (Circulating Tumor Cells, Extracellular Vesicles, Circulating Tumor DNA), By Application (Diagnostics, Prognostics, Risk assessment), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031 📚 𝐆𝐞𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐩𝐫𝐢𝐜𝐞:👇 https://lnkd.in/dGFiQBcX 📚𝐓𝐨𝐩 𝐌𝐨𝐫𝐞 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐀𝐫𝐞::👇 Adaptive Biotechnologies Corp. Bio-Rad Laboratories. Biocept, Inc. Biodesix, Inc. Cardiff Oncology. Epic Sciences. Exact Sciences. Exosome Diagnostics. F. Hoffmann-La Roche Ltd Fluxion Biosciences Genomic Health. Guardant Health Illumina Isogen Life Science Johnson & Johnson Menarini Silicon Biosystems Mirxes. Myriad Genetics NeoGenomics Laboratories QIAGEN Sysmex Corporation Thermo Fisher Scientific #liquidbiopsy #t #nextgenerationsequencing #genetiktan #cancer #caninecancer #oncok #theliquidbiopsycompanyforpets #theliquidbiopsytestfordogs #dogsofinstagram #veterinariansofinstagram #vetsofinstagram #vetclinic #petdx #cancertest #genomics #bloodtest #cancerscreening #cancerdetectiondogs #cancerdetection #vetoncology #biotechnology #veterinaryscience #vetscience #vetmed #biotech #veterinarymedicine #moleculardiagnostics #caninehealth #likitbiyopsi

#NGS_Sample_Preparation Market is estimated to Grow at the Highest Growth Rate till 2023-2032 https://lnkd.in/gdmuT3D7 The key drivers impacting the #NGS sample #preparation market are the initiatives and funding from #government & private bodies for large-scale sequencing projects. The rising #development of companion #diagnostics and personalized medicine will likely augment #NGS sample preparation #demand in the forecast period. Congenica Agilent Technologies BGI Genomics Biomatter Bio-Rad Laboratories DNASTAR Roche Eurofins Eurofins Advinus Genomatix AG Scientific Seminars International Foundation MacroGenics, Inc. Macrogen Inc. Illumina Myriad Genetics PACIFIC BIOSCIENCES OF CALIF Oxford Nanopore Technologies PerkinElmer Partek, an Illumina company Pierian Services Quest Diagnostics Quest Diagnostics Oncology QIAGEN QIAGEN Wrocław Thermo Fisher Scientific

Reviewing ten years of research on extracellular vesicle-associated DNA: Thupten Tsering, Julia V. Burnier at McGill University and collaborators explored the mechanisms of EV-DNA release, its biomarker potential, functional roles, conflicting findings in the field, and the challenges impeding its clinical application https://lnkd.in/eskD_8x2 The authors anticipate that advances in EV isolation and detection methods, along with better standardisation and data sharing, will drive the development of innovative strategies leveraging EV-DNA as a source of biomarkers and therapeutic targets. An article co-authored by Amélie Nadeau, Tad Wu and Kyle Dickinson #extracellularvesicles #exosomes #biomarkers #cellbiology #Vesiculab

🚀 🧑🔬 Spend your time running experiments, not generating your CRISPR-engineered CHO cell line🧪🔧 🧬 Reliable, high-quality engineered #CHO cell lines are a versatile tool in biotechnology and biomedical research, contributing significantly to advancements in drug development, genetic engineering, and therapeutic protein production. 🔬✨ 🔍 With the CellEDIT workflow, we can efficiently generate custom-engineered CHO cell lines through direct intra-nuclear injection, designed to suit your project needs. 🔗 Discover how the CellEDIT workflow boosted editing efficiency while maintaining cell characteristics and functionality in single and multiple KO CHO-K1 clones👉 Find out more 👉https://bit.ly/4bc7hUR #FluidFM #CancerResearch #Research #oncology #DrugDevelopment #Genetics #CellBiology #CRISPR #CellEngineering #GeneEditing #singlecell #Biotech #ResearchInnovation #CellEDIT #ScientificResearch #Biotechnology #LabLife #Science #Innovation

Join Nicoya at their upcoming webinar, “Label-free characterization of challenging transmembrane proteins using Alto™ digital SPR” 📆 Thursday, 20 June 2024 🕖 16:30 SAST Register today ➡️ https://lnkd.in/deV_duYe You’ll discover: ✓ Nicoya’s cutting-edge digital SPR platform Alto™, which is revolutionizing the analytical development of biologically relevant multi-pass transmembrane proteins and overcoming industry challenges. ✓ Learn about ACROBiosystems' dynamic suite of stabilized multi-pass TPs, featuring key therapeutic targets like CD20, Claudin18.2, CD133, and more. ✓ Gain insights into the potential of leveraging Alto digital SPR and ACROBiosystems transmembrane proteins for developing novel therapeutics for cellular and genetic disorders. #webinar #digitalSPR #transmembrane #proteins #science #biotech 

 ✨ The B6-HATXN3 mouse model is a significant advancement in SCA3 research, offering crucial insights into the genetic mutations causing spinocerebellar ataxia type 3. ✅ This model closely mirrors SCA3's pathology, aiding in preclinical studies, biomarker identification, and therapy evaluation. ✅ The TurboKnockout technology enhances its versatility for genetic diversity representation in patients, supporting drug screening and pharmacological studies. Cyagen's introduction of the B6-HATXN3 model highlights their commitment to medical research progress in SCA3 treatment. Learn more about this mouse model here: https://lnkd.in/d9iRFQmr #mousemodels #preclinicalresearch #research #science #biotech #biotechnology #genetherapy

Very interestin review highlighting not only DNA in EVs but also mecanism of secretion!

𝐆𝐫𝐨𝐰𝐭𝐡 𝐒𝐮𝐫𝐠𝐞: 𝐌𝐢𝐜𝐫𝐨𝐚𝐫𝐫𝐚𝐲 𝐊𝐢𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐭 𝐭𝐨 𝐀𝐜𝐡𝐢𝐞𝐯𝐞 $𝟐.𝟓𝟏 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐕𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏 » 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://lnkd.in/ec2HcbJT According to a recent report from Meticulous Research®, the #microarray_kits_market is anticipated to reach $2.51 billion by 2031, expanding at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031. This impressive growth is fueled by several key factors. First and foremost, the increasing application of microarrays in various research fields is a significant driver. In particular, their role in cancer research has gained prominence, as microarrays enable the analysis of gene expression profiles, facilitating the identification of #biomarkers and #therapeutic targets. Moreover, the rising trend of personalized #medicine is contributing to the market's expansion. As healthcare shifts toward #tailored_treatments, microarrays are becoming essential tools for understanding individual genetic profiles. Additionally, the growing investments in research and development within the #pharmaceutical and #biotechnology sectors are further propelling the demand for microarray kits.   » 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck Group, PerkinElmer, QIAGEN N.V., Edvotek Inc, Sakura Finetek Europe , Dextra Group, GeneCopoeia.   » 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 : • 𝗡𝗲𝘂𝗿𝗼𝗺𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/durzqeWc • 𝗩𝗲𝘁𝗲𝗿𝗶𝗻𝗮𝗿𝘆 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/dV2HS5Xx • 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/d4tRZYXH   #MicroarrayKits #GenomicResearch #BiotechInnovation #DNAAnalysis #GeneExpression #MolecularDiagnostics #HighThroughputScreening #OmicsTechnology #PersonalizedMedicine #CancerResearch #PharmaceuticalDevelopment #Bioinformatics #LaboratoryEquipment #ResearchTools #BiologicalSciences #GenomeMapping #MicroarrayTechnology #ClinicalResearch #GeneticTesting #LifeS ciences

More exciting news from Crown about #Organoids! 💡 👇 OrganoidXplore™, developed by Crown Bioscience, is a large-scale organoid panel screen, executed every three months, in which clients can include their compounds for testing on organoid viability. This assay-ready service processes up to 50 models in as little as 6 weeks ensuring your research stays ahead of the curve with rapid, data-driven decision making. It comprises a genetically characterized heterogeneous panel of tumor organoids and matching organoids derived from healthy epithelium from the same patients. Learn more in this blog post!